Pricing Log in Create free account

Faeth Therapeutics, Inc. (FTH) vs Valneva SE Sponsored ADR (VALN)

Faeth Therapeutics, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Faeth Therapeutics, Inc. and Valneva SE Sponsored ADR are of similar size ($560.4M and $532.3M). Faeth Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 59.7×. Faeth Therapeutics, Inc. has the higher net margin (0.00% vs −12.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Valneva SE Sponsored ADR leads on 7 and Faeth Therapeutics, Inc. on 6.

Valuation

Metric FTH VALN Biotechnology median
P/E n/m 59.68 8.50
P/S n/m 3.05 9.71
P/B 0.61 5.30 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.32 42.91 0.64
EV/Sales n/m 3.49 9.21
Earnings yield (753.86%) 1.68% (33.15%)
Free cash flow yield (31.94%) (11.78%) (25.50%)

Profitability

Metric FTH VALN Biotechnology median
Gross margin 0.00% 38.28% 65.16%
Operating margin 0.00% 13.56% 0.00%
Net margin 0.00% (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (195.26%) 0.00% (56.36%)
Return on assets (176.88%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FTH VALN Biotechnology median
Revenue growth (TTM) — (53.16%) 6.02%
EPS growth (last fiscal year) 30.33% (805.88%) 30.26%
Revenue growth, 5-year CAGR — 9.41% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTH VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 19.69 2.16 4.72
Net debt to EBITDA 0.96 (1.15) 0.96

Dividend

Metric FTH VALN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FTH VALN Biotechnology median
Market cap 532.31m 560.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack